Growing Diagnostics Hemosure has a proven foothold in fecal occult blood testing with its iFOB and now offers an FDA-cleared automated Accu-Reader A 100 system, presenting a strong opportunity to upsell integrated diagnostic workflows and automated processing to clinics and labs.

Automation Advantage The Accu-Reader A 100 automation promises faster 5-minute results, enabling healthcare facilities to increase throughput and reduce manual labor, which can be pitched to high-volume labs and gastroenterology centers seeking efficiency gains.

Regional Presence Located near Los Angeles with proximity to medical professionals and institutions, there is a strategic sales runway in Southern California for hospital systems, independent labs, and specialty clinics looking for local suppliers and quick support.

Tech Stack Alignment Use of modern ecommerce and cloud tools (Wix, WooCommerce, Google Cloud) indicates a capability to scale digital sales, online demos, and remote onboarding, which can be leveraged to streamline procurement, trials, and customer onboarding for new buyers.

Financial Growth Path Reported revenue in the $10–$25M band suggests a scalable, mid-market footprint with room to expand through broader product adoption, cross-selling of the iFOB line with the Accu-Reader system, and expansion into new regional markets and patient diagnostics services.